Paul Whiteaker

6.1k total citations · 1 hit paper
91 papers, 5.0k citations indexed

About

Paul Whiteaker is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Paul Whiteaker has authored 91 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 15 papers in Pharmacology. Recurrent topics in Paul Whiteaker's work include Nicotinic Acetylcholine Receptors Study (90 papers), Receptor Mechanisms and Signaling (72 papers) and Ion channel regulation and function (28 papers). Paul Whiteaker is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (90 papers), Receptor Mechanisms and Signaling (72 papers) and Ion channel regulation and function (28 papers). Paul Whiteaker collaborates with scholars based in United States, China and United Kingdom. Paul Whiteaker's co-authors include Michael J. Marks, Allan C. Collins, J. Michael McIntosh, Sharon R. Grady, Henry A. Lester, Jon Lindstrom, Ronald J. Lukas, Sheri McKinney, Susan Wonnacott and Outi Salminen and has published in prestigious journals such as Science, Journal of Biological Chemistry and Neuron.

In The Last Decade

Paul Whiteaker

90 papers receiving 4.9k citations

Hit Papers

Nicotine Activation of α4* Receptors: Sufficient for Rewa... 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
    2004 539 citations Andrew R. Tapper, Sheri McKinney et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Whiteaker United States 40 4.6k 2.1k 596 452 409 91 5.0k
Milena Moretti Italy 33 3.5k 0.8× 1.7k 0.8× 530 0.9× 356 0.8× 320 0.8× 69 4.1k
Alexander Kuryatov United States 31 3.8k 0.8× 1.7k 0.8× 497 0.8× 310 0.7× 324 0.8× 59 4.3k
Sharon R. Grady United States 34 4.1k 0.9× 2.3k 1.1× 466 0.8× 355 0.8× 295 0.7× 63 4.5k
Lisa M. Marubio United States 18 3.3k 0.7× 2.0k 1.0× 404 0.7× 588 1.3× 254 0.6× 21 4.0k
Jerry A. Stitzel United States 34 2.7k 0.6× 1.2k 0.6× 319 0.5× 590 1.3× 297 0.7× 82 3.2k
Merouane Bencherif United States 31 2.5k 0.6× 971 0.5× 584 1.0× 274 0.6× 125 0.3× 74 3.0k
Raymond S Hurst United States 26 3.4k 0.7× 2.4k 1.2× 379 0.6× 517 1.1× 140 0.3× 42 4.6k
Roderick H. Scott United Kingdom 35 2.6k 0.6× 2.3k 1.1× 483 0.8× 764 1.7× 90 0.2× 93 3.9k
Cecilia Bouzat Argentina 32 2.9k 0.6× 866 0.4× 404 0.7× 95 0.2× 308 0.8× 108 3.5k
Sheri McKinney United States 22 1.9k 0.4× 1.4k 0.7× 170 0.3× 313 0.7× 164 0.4× 27 2.4k

Countries citing papers authored by Paul Whiteaker

Since Specialization
Citations

This map shows the geographic impact of Paul Whiteaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Whiteaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Whiteaker more than expected).

Fields of papers citing papers by Paul Whiteaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Whiteaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Whiteaker. The network helps show where Paul Whiteaker may publish in the future.

Co-authorship network of co-authors of Paul Whiteaker

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Whiteaker. A scholar is included among the top collaborators of Paul Whiteaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Whiteaker. Paul Whiteaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
George, Andrew A., Linda Lucero, J. Brek Eaton, et al.. (2023). Analogs of α‐conotoxin PnIC selectively inhibit α7β2‐ over α7‐only subtype nicotinic acetylcholine receptors via a novel allosteric mechanism. The FASEB Journal. 38(1). e23374–e23374. 4 indexed citations
2.
Pallavicini, Marco, Susanna Pucci, Linda Lucero, et al.. (2022). From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue. Journal of Medicinal Chemistry. 65(14). 10079–10097. 10 indexed citations
3.
Pallavicini, Marco, Susanna Pucci, Linda Lucero, et al.. (2022). Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624). Journal of Medicinal Chemistry. 66(1). 306–332. 8 indexed citations
4.
Cao, Wenpeng, K. Anderson, Paul Whiteaker, et al.. (2021). Biophysical characterization of lynx‐nicotinic receptor interactions using atomic force microscopy. FASEB BioAdvances. 3(12). 1034–1042. 5 indexed citations
5.
Weltzin, Maegan M., Andrew A. George, Ronald J. Lukas, & Paul Whiteaker. (2021). Sleep-related hypermotor epilepsy associated mutations uncover important kinetic roles of α4β2- nicotinic acetylcholine receptor intracellular structures. PLoS ONE. 16(3). e0247825–e0247825. 3 indexed citations
6.
Lucero, Linda, Maegan M. Weltzin, J. Brek Eaton, et al.. (2015). Differential α4(+)/(−)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms. Journal of Biological Chemistry. 291(5). 2444–2459. 24 indexed citations
7.
Weltzin, Maegan M., Jon Lindstrom, Ronald J. Lukas, & Paul Whiteaker. (2015). Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy. Neuropharmacology. 102. 158–173. 21 indexed citations
8.
Moretti, Milena, Michèle Zoli, Andrew A. George, et al.. (2014). The Novel α7β2-Nicotinic Acetylcholine Receptor Subtype Is Expressed in Mouse and Human Basal Forebrain: Biochemical and Pharmacological Characterization. Molecular Pharmacology. 86(3). 306–317. 69 indexed citations
9.
Murray, Teresa A., Daniel Bertrand, Roger L. Papke, et al.. (2011). α7β2 Nicotinic Acetylcholine Receptors Assemble, Function, and Are Activated Primarily via Their α7-α7 Interfaces. Molecular Pharmacology. 81(2). 175–188. 54 indexed citations
10.
Yang, Kechun, Lori M. Buhlman, Ghous M. Khan, et al.. (2011). Functional Nicotinic Acetylcholine Receptors Containing α6 Subunits Are on GABAergic Neuronal Boutons Adherent to Ventral Tegmental Area Dopamine Neurons. Journal of Neuroscience. 31(7). 2537–2548. 67 indexed citations
11.
Collins, Allan C., Outi Salminen, Michael J. Marks, Paul Whiteaker, & Sharon R. Grady. (2009). The Road to Discovery of Neuronal Nicotinic Cholinergic Receptor Subtypes. Handbook of experimental pharmacology. 85–112. 24 indexed citations
12.
Hone, Arik J., Paul Whiteaker, Sean Christensen, et al.. (2009). A novel fluorescent α‐conotoxin for the study of α7 nicotinic acetylcholine receptors. Journal of Neurochemistry. 111(1). 80–89. 28 indexed citations
13.
Drenan, Ryan M., Sharon R. Grady, Paul Whiteaker, et al.. (2008). In Vivo Activation of Midbrain Dopamine Neurons via Sensitized, High-Affinity α6∗ Nicotinic Acetylcholine Receptors. Neuron. 60(1). 123–136. 168 indexed citations
14.
Grady, Sharon R., Outi Salminen, Duncan Laverty, et al.. (2007). The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochemical Pharmacology. 74(8). 1235–1246. 206 indexed citations
15.
Whiteaker, Paul, John F. Cooper, Outi Salminen, et al.. (2006). Immunolabeling demonstrates the interdependence of mouse brain α4 and β2 nicotinic acetylcholine receptor subunit expression. The Journal of Comparative Neurology. 499(6). 1016–1038. 42 indexed citations
16.
Gotti, Cecilia, Milena Moretti, Francesco Clementi, et al.. (2005). Expression of Nigrostriatal α6-Containing Nicotinic Acetylcholine Receptors Is Selectively Reduced, but Not Eliminated, by β3 Subunit Gene Deletion. Molecular Pharmacology. 67(6). 2007–2015. 117 indexed citations
17.
Tapper, Andrew R., Sheri McKinney, Raad Nashmi, et al.. (2004). Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization. Science. 306(5698). 1029–1032. 539 indexed citations breakdown →
18.
Quik, Maryka, Paul Whiteaker, Sarah E. McCallum, et al.. (2003). Differential Declines in Striatal Nicotinic Receptor Subtype Function after Nigrostriatal Damage in Mice. Molecular Pharmacology. 63(5). 1169–1179. 75 indexed citations
19.
Whiteaker, Paul, Michael J. Marks, Sharon R. Grady, et al.. (2000). Pharmacological and null mutation approaches reveal nicotinic receptor diversity. European Journal of Pharmacology. 393(1-3). 123–135. 44 indexed citations
20.
Whiteaker, Paul, Andrew R. Davies, Michael J. Marks, et al.. (1999). An autoradiographic study of the distribution of binding sites for the novel α7‐selective nicotinic radioligand [3H]‐methyllycaconitine in the mouse brain. European Journal of Neuroscience. 11(8). 2689–2696. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milena Moretti Breakdown of academic impact, for papers by Alexander Kuryatov Breakdown of academic impact, for papers by Sharon R. Grady Breakdown of academic impact, for papers by Lisa M. Marubio Breakdown of academic impact, for papers by Jerry A. Stitzel Breakdown of academic impact, for papers by Merouane Bencherif Breakdown of academic impact, for papers by Raymond S Hurst Breakdown of academic impact, for papers by Roderick H. Scott Breakdown of academic impact, for papers by Cecilia Bouzat Breakdown of academic impact, for papers by Sheri McKinney
Rankless by CCL
2026